dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2019-07-04T07:14:08Z |
dc.date.available | 2019-07-04T07:14:08Z |
dc.date.issued | 2019-02-20 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Empagliflozina/linagliptina per al tractament de la diabetis mellitus tipus 2. Barcelona: Servei Català de la Salut; 2019. |
dc.identifier.uri | https://hdl.handle.net/11351/4176 |
dc.description | Diabetes mellitus type 2; Empagliflozin; Linagliptin; Combination |
dc.description.abstract | The combination of fixed doses (CDF) of empagliflozin and linagliptin (EMPA / LINA) includes a type 2 sodium-glucose (ISGLT2) and a dipeptidylpeptidase inhibitor type-4 (IDPP4) inhibitor. It is indicated as an adjunct to the diet in patients with diabetes mellitus type 2 (DM2) with poor control, treated with metformin and / or sulfonylurea and one of the CDF components or pretreated patients with the two monocomponents. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.relation.ispartof | Programa d'Harmonització Farmacoterapèutica, Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Diabetis no-insulinodependent - Tractament |
dc.subject | Medicaments - Assaigs clínics |
dc.subject.mesh | Linagliptin |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Diabetes Mellitus, Type 2 |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Clinical Trial, Phase III |
dc.title | Empagliflozina/linagliptina per al tractament de la diabetis mellitus tipus 2 |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | linagliptina |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | diabetes mellitus tipo II |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | ensayo clínico fase III |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |